Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Drug Use-results Survey on Quetiapine Extended-release Tablets in Patients With Depression in Bipolar Disorder

NCT03403790 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT03403790
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03403790 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Drug Use-results Survey on Quetiapine Extended-release Tablets in Patients With Depression in Bipolar Disorder
Lead sponsor
Astellas Pharma Inc
Phase
Observational
Overall status
Completed
Start date
January 15, 2018
Completion date
March 19, 2020
Enrollment
369 (actual)
Sites
47

Conditions

As the registry lists them; a condition with its own page is linked.

bipolar disorder, depression